Frederick Goar

United States; Mountain View California United States; California United States; North America
Is it you?
Investor info
Type
Angel Investors
Stage focus
  • Seed Round
Industry focus
Description
Frederick Goar serves as Vice Chairman of the Board at Fogarty Institute for Innovation. He also serves as Advisor at Vida Syste A board certified interventional cardiologist at El Camino Hospital, Dr. St. Goar pursues a clinical practice along with successful, active participation in the cardiovascular medical device industry. His work has focused on cardiac interventions, and he has a special interest in structural heart disease. He has published extensively , is listed on multiple new device patents and is recognized as a thought leader in the area of valvular heart disease. He has served as a consultant for both start-ups and established medical device companies. Companies that he has worked with recently include Ardian, Nanostim, and HeartFlow. His entrepreneurial work includes helping to found Evalve, and HeartPort. Dr. St Goar participates closely with the Fogarty Institute Innovation program and teaches at Stanford Medical School in the BioDesign program.
Relevant investments
  • Company
    Amount
    Round
  • Example example company Inc
    $ 1,000,000
    Investor meetings
  • Company & Company
    € 11,000,000
    Series C funding
  • Example
    $ 524,000
    Seed round A
Show more
Connected people
Email visible after logging in
  • Example Example
    Example Exampleexample[email protected]
  • Example Exampleexample
    Example Exampleexample
  • Notexample Examplenot
    Notexample Examplenotexample example[email protected]
  • Example Examplenotexample
    Example Examplenotexampleexample example[email protected]
  • Example Example
    Example Exampleexample[email protected]
  • Example Example
    Example Exampleexample[email protected]
Show more
See other investors focused on
Investment Management
Made with in San Francisco, Valencia, Oslo, Cherkasy and Warsaw© 2015-     Foundersuite, Inc.